Search

Search Results
Results 7291 - 7300 of 7303 for Neurodegenerative Diseases
  • The Francis Crick Institute
    Supplier - 24 Jan 2019
    The Francis Crick Institute is dedicated to understanding the fundamental biology underlying health and disease.
  • Denali Therapeutics Inc.
    Supplier - 19 Mar 2026
    Denali Therapeutics Inc. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using our proprietary TransportVehicle™ platform.
  • TRIMTECH Therapeutics
    Supplier - 7 Mar 2025
    Developer of a targeted protein degradation platform designed to address neurodegenerative diseases by degrading toxic protein aggregates. The company's platform offers oral therapeutics with...
  • SignalChem Biotech Inc.
    Supplier - 16 Apr 2020
    SignalChem is a biotech company focused on the research, development, and production of innovative and high-quality human recombinant cell signaling products.
  • Hanson Wade Group - 8th Neuroimmunology Drug Development Summit 2026
    Supplier - 24 Jan 2026
    Translating Discoveries of Glial Biology & Peripheral Immune Pathways into Novel Approaches to Target Neuroinflammation Across the Neurodegenerative Disease Spectrum
  • Neurodegenerative Drug Development
    Supplier - 4 Apr 2019
    Focused on neurodegenerative disease, the drug development community will assemble at NDD Europe to overcome the translational challenges blocking the development of clinically disease modifying...
  • World CNS Summit
    Supplier - 18 Dec 2018
    Attend the 7th World CNS Summit in Boston
  • REPROCELL
    Supplier - 17 Dec 2020
    Established in 2003 by preeminent Japanese university researchers, REPROCELL quickly became the leading stem cell research company in Japan.
  • RQM+
    Supplier - 21 Jul 2022
    Two industry leaders—R&Q and Maetrics—merged in 2020 to become RQM+, the largest medical device and diagnostics focused full-service regulatory and quality consulting firm in the world. The...
  • 2nd Annual Neuroimmunology Drug Development Summit
    Supplier - 30 Jan 2020
    The 2nd Annual Neuroimmunology Drug Development Summit is the industry’s definitive conference specifically designed to overcome the translational challenges of neuroimmunological drug development.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback